Image

Neural Contributions to Exercise-Induced Hypoalgesia With Blood Flow Restriction

Neural Contributions to Exercise-Induced Hypoalgesia With Blood Flow Restriction

Recruiting
18-35 years
All
Phase N/A

Powered by AI

Overview

This experimental study explores the neurophysiological mechanisms associated with pain modulation following a single session of low-intensity resistance exercise combined with BFR in healthy young adults. The study evaluates changes in sensory thresholds before and after the intervention using validated quantitative sensory testing (QST) methods. These include pressure pain thresholds, conditioned pain modulation, thermal thresholds, and temporal summation. The findings may contribute to a better understanding of the role of the nervous system in exercise-induced hypoalgesia, particularly in response to BFR protocols, with implications for future research in pain and rehabilitation.

Description

Exercise-induced hypoalgesia (EIH) is a physiological response characterized by reduced pain sensitivity following physical activity. Several central and peripheral mechanisms have been proposed to explain EIH, including activation of descending inhibitory pathways and peripheral nociceptor modulation. BFR training involves the application of controlled vascular occlusion during low-load exercise and has shown promising results in enhancing both muscle function and pain modulation.

This is a single-arm, pre-post experimental study involving healthy adults aged 18-35 years. All participants undergo a single session of low-intensity resistance exercise involving the lower limbs, performed under 60% limb occlusion pressure. QST is performed before and immediately after the intervention, including:

Pressure Pain Thresholds (PPT) measured with a digital algometer

Conditioned Pain Modulation (CPM) using cold-water immersion

Thermal thresholds assessed with a computer-controlled thermode

Temporal summation (TS) of pain via repeated pressure stimuli

The aim of this study is to explore the involvement of neurophysiological mechanisms-both central and peripheral-in the pain modulatory response following BFR exercise. This study is conducted at CUADI (Centro Universitario de Asistencia, Docencia e Investigación) in Rosario, Argentina. The results will contribute to basic science knowledge on pain physiology in healthy individuals and may inform future applied research in rehabilitation contexts.

Sample size considerations:

The estimated sample size is approximately 20 participants. This number is based on a preliminary power analysis conducted from pilot data on PPT changes following cold water immersion, which showed a mean difference of 0.77 kgf with a standard deviation of 0.33 kgf. Using G*Power software (v3.1), the calculated sample size for a paired comparison with 95% power and alpha of 0.05 was 16 subjects. To account for potential data loss or dropouts, we plan to include at least 20 individuals. This sample size is considered adequate for a mechanistic, single-arm pre-post design focusing on within-subject changes in pain modulation outcomes.

Eligibility

Inclusion Criteria:

  • Asymptomatic at the time of evaluation.
  • Able to provide written informed consent.
  • Available to attend a single evaluation and intervention session at the research center.

Exclusion Criteria:

  • Bilateral knee symptoms or suspected patellar tendinopathy.
  • Increased symptoms with dynamic loading.
  • Neurological disorders.
  • Inflammatory rheumatic diseases.
  • Cardiac diseases.
  • Any surgery within the last 3 months.
  • Pregnancy.
  • Alcohol consumption on the day of participation.
  • Hypertension (systolic blood pressure ≥140 mmHg).
  • History of deep vein thrombosis.
  • History of endothelial dysfunction.
  • Peripheral vascular disease.
  • Diabetes.
  • Active infection.
  • Spinal or referred pain.
  • Previous experience with blood flow restriction (BFR) training.
  • Overweight or obesity.

Study details
    Healthy

NCT07122011

University of Gran Rosario

21 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.